Skip to main navigation
We have recently updated our Privacy Policy to include information regarding the cookies we collect. By continuing to use this website you agree to our Privacy Policy and Terms of Use .
ACCEPT
Sage Therapeutics
  • Patients & Care Partners

    Patients & Care Partners

    • Patient Advocacy
    • Patient Advocacy Sponsorships & Grants
    • Patient Support
  • Healthcare Providers

    Healthcare Providers

    • Visit the Sage Medical Hub
  • Our Medicines
  • Therapeutic Focus

    Therapeutic Focus

    • A New Approach to Brain Health Disorders
    • GABA & NMDA Receptors
  • Programs & Research

    Programs & Research

    • Depression Franchise
    • Neurology Franchise
    • Neuropsychiatry Franchise
    • Pipeline
    • Clinical Trials
    • Early Access
    • Collaborations
  • About Us

    About Us

    • Mission & Values
    • Corporate Governance
    • Our Team
    • Partnering
    • Corporate Social Responsibility
    • Funding & Giving
  • Working at Sage
  • Investors/Media
  • Clinical Trials
  • Contact Us

Investors & Media

Event Details

Investor Relations

  • Overview
  • Corporate Governance
  • Press Releases & Statements
  • Events & Presentations
  • SEC Filings
  • Annuals and Proxies
  • Investor FAQs
  • Financials & Filings
  • Stock Information
  • Analyst Coverage
  • Email Alerts Subscription
  • Notice of Pendency of Settlement of Action

Sage Therapeutics Q3 2017 Financial Results

Nov 2, 2017 8:00 AM EDT

Listen to Webcast

Patients & Care Partners

  • Patient Advocacy
  • Patient Advocacy Sponsorships & Grants
  • Patient Support

Healthcare Providers

  • Visit the Sage Medical Hub

Our Medicines

Therapeutic Focus

  • A New Approach to Brain Health Disorders
  • GABA & NMDA Receptors

Programs & Research

  • Depression Franchise
  • Neurology Franchise
  • Neuropsychiatry Franchise
  • Pipeline
  • Clinical Trials
  • Collaborations

About Us

  • Mission & Values
  • Corporate Governance
  • Our Team
  • Partnering
  • Corporate Social Responsibility
  • Funding & Giving

Working at Sage

  • Investors/Media
  • Clinical Trials
  • Contact Us
  • Facebook Sage Therapeutics - Facebook
  • Twitter Sage Therapeutics - Twitter
  • Instagram Sage Therapeutics - Instagram
  • LinkedIn Sage Therapeutics - LinkedIn

© Sage Therapeutics, Inc

  • Privacy Policy
  • Terms of Use
  • Community Guidelines
  • Accessibility
  • Site Map

SAGE THERAPEUTICS, the SAGE THERAPEUTICS logo, and ZURZUVAE are registered trademarks of Sage Therapeutics, Inc. The ZURZUVAE logo is a trademark of Sage Therapeutics, Inc. All other trademarks referenced herein are the property of their respective owners.